218 related articles for article (PubMed ID: 30778428)
1. The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A.
Reelfs O; Abbate V; Cilibrizzi A; Pook MA; Hider RC; Pourzand C
Metallomics; 2019 Mar; 11(3):656-665. PubMed ID: 30778428
[TBL] [Abstract][Full Text] [Related]
2. A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation.
Reelfs O; Abbate V; Hider RC; Pourzand C
J Invest Dermatol; 2016 Aug; 136(8):1692-1700. PubMed ID: 27109868
[TBL] [Abstract][Full Text] [Related]
3. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.
Wong A; Yang J; Cavadini P; Gellera C; Lonnerdal B; Taroni F; Cortopassi G
Hum Mol Genet; 1999 Mar; 8(3):425-30. PubMed ID: 9949201
[TBL] [Abstract][Full Text] [Related]
4. Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?
Sturm B; Bistrich U; Schranzhofer M; Sarsero JP; Rauen U; Scheiber-Mojdehkar B; de Groot H; Ioannou P; Petrat F
J Biol Chem; 2005 Feb; 280(8):6701-8. PubMed ID: 15615730
[TBL] [Abstract][Full Text] [Related]
5. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
[TBL] [Abstract][Full Text] [Related]
6. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
[TBL] [Abstract][Full Text] [Related]
7. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction in friedreich's ataxia.
Lodi R; Taylor DJ; Schapira AH
Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
[TBL] [Abstract][Full Text] [Related]
9. Caged-iron chelators a novel approach towards protecting skin cells against UVA-induced necrotic cell death.
Yiakouvaki A; Savović J; Al-Qenaei A; Dowden J; Pourzand C
J Invest Dermatol; 2006 Oct; 126(10):2287-95. PubMed ID: 16710308
[TBL] [Abstract][Full Text] [Related]
10. Friedreich's ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?
Richardson DR
Expert Opin Investig Drugs; 2003 Feb; 12(2):235-45. PubMed ID: 12556217
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts.
Reelfs O; Tyrrell RM; Pourzand C
J Invest Dermatol; 2004 Jun; 122(6):1440-7. PubMed ID: 15175035
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.
Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM
Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of skin cells to UVA-induced necrotic cell death reflects the intracellular level of labile iron.
Zhong JL; Yiakouvaki A; Holley P; Tyrrell RM; Pourzand C
J Invest Dermatol; 2004 Oct; 123(4):771-80. PubMed ID: 15373784
[TBL] [Abstract][Full Text] [Related]
15. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.
Tan G; Chen LS; Lonnerdal B; Gellera C; Taroni FA; Cortopassi GA
Hum Mol Genet; 2001 Sep; 10(19):2099-107. PubMed ID: 11590127
[TBL] [Abstract][Full Text] [Related]
16. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
[TBL] [Abstract][Full Text] [Related]
17. Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts.
Richardson TE; Yu AE; Wen Y; Yang SH; Simpkins JW
PLoS One; 2012; 7(4):e34600. PubMed ID: 22509330
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts.
García-Giménez JL; Gimeno A; Gonzalez-Cabo P; Dasí F; Bolinches-Amorós A; Mollá B; Palau F; Pallardó FV
PLoS One; 2011; 6(6):e20666. PubMed ID: 21687738
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
[TBL] [Abstract][Full Text] [Related]
20. Skin protection against UVA-induced iron damage by multiantioxidants and iron chelating drugs/prodrugs.
Reelfs O; Eggleston IM; Pourzand C
Curr Drug Metab; 2010 Mar; 11(3):242-9. PubMed ID: 20406189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
